SCHEMBL5966655

SCHEMBL5966655

CC(C)(C)OC(=O)N1C(=O)CCCC1Cc1ccc(Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.42
HCRTR2 O43614 1/20 0.42
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
VEGFA P15692 1/20 0.39
EGLN1 Q9GZT9 1/20 0.39
STS P08842 2/20 0.39
TSHR P16473 1/20 0.39
NPSR1 Q6W5P4 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HTT P42858 1/20 0.39
KLK7 P49862 1/20 0.38
OPRK1 P41145 1/20 0.38
ALDH1A1 P00352 2/20 0.37
USP2 O75604 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
CACNA1B Q00975 1/20 0.37
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26439216 0.93 VEGFA (0.41) MEN1KMT2AVEGFAEGLN1STS
SCHEMBL26707683 0.93 VEGFA (0.41) MEN1KMT2AVEGFAEGLN1STS
SCHEMBL29997809 0.87 KLK7 (0.48) KMT2ASTSKLK7
SCHEMBL6969013 0.87 KLK7 (0.48) KMT2ASTSKLK7
SCHEMBL12241769 0.82 TP53 (0.45) MEN1KMT2ATSHRNPSR1SMN1; SMN2
SCHEMBL14902419 0.82 MME (0.38) MEN1KMT2AVEGFAEGLN1TSHR
SCHEMBL5888448 0.82 YAP1 (0.47) MEN1KMT2ASMN1; SMN2KLK7LMNA
SCHEMBL5888451 0.82 YAP1 (0.47) MEN1KMT2ASMN1; SMN2KLK7LMNA
SCHEMBL22154819 0.81 KLK7 (0.39) HCRTR1HCRTR2MEN1KMT2AHTT
SCHEMBL9929842 0.81 FPR2 (0.39) KMT2AKLK7CACNA1BTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060128613-A1 Melanocortin receptor ligands THE PROCTER & GAMBLE COMPANY 2006-06-15 US disclosed
EP-1409540-A2 MELANOCORTIN RECEPTOR LIGANDS THE PROCTER & GAMBLE COMPANY (US) 2004-04-21 EP disclosed
WO-2002026774-A2 MELANOCORTIN RECEPTOR LIGANDS THE PROCTER & GAMBLE COMPANY (US) 2002-04-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060128613-A1 Melanocortin receptor ligands MC3R, MC4R, MC1R HCRTR1 58/4885HCRTR2 77/4885MEN1 511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.